title: Existing data sources for clinical epidemiology: Scandinavian Cohort for osteonecrosis of the jaw - work in progress and challenges.
abstract: Osteonecrosis of the jaw (ONJ) is a severe side effect associated with antiresorptive treatment. Monitoring of ONJ using routine databases in Scandinavian countries is a challenge owing to lack of valid algorithms and to heterogeneous referral practices. The aim of this paper is to describe the process of establishing a Scandinavian ONJ Cohort enrolling all ONJ cases related to antiresorptive treatment arising in Denmark, Norway, and Sweden between 2011 and 2019. The initial purpose of the cohort is to support an ongoing pharmacovigilance study of denosumab and zoledronic acid in Denmark, Norway, and Sweden. The three countries, with their 199 clinics, departments, and units of oral and maxillofacial surgery, both hospital-based and freestanding, differ somewhat in referral practices of the ONJ patients. By directly contacting all providers of care to ONJ patients in the three countries, we established a network for reporting incident cases to each country's research database directly or through a member of the Scandinavian ONJ task force as a liaison. The task force includes a Scandinavian coordinator and three national coordinators collaborating directly with the clinics. A uniform ONJ registration form has been developed, and the relevant medical community has been informed either directly or through presentations at professional meetings. A website with study information is published in each country, and data entry is ongoing. This large-scale systematic uniform registration of ONJ cases in Denmark, Norway, and Sweden, with an underlying total population of more than 20 million people, merged into the Scandinavian ONJ Cohort, will contribute to better knowledge and understanding of this challenging group of patients, and ultimately, help improve patient care. The Scandinavian ONJ Cohort as a whole and its component national ONJ research databases may offer the potential for large-scale multinational intervention and safety studies in the future.
authors: Department of Oral and Maxillofacial Surgery, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
authors: Morten
authors: M
authors: Schiodt
authors: Department of Oral and Maxillofacial Surgery, Södra Älvsborg Hospital, Region Västra Götaland, Borås, Sweden ; Department of Biomaterials, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
authors: Cecilia
authors: C
authors: Larsson Wexell
authors: Department of Oral Surgery and Oral Medicine, Faculty of Dentistry, University of Oslo, Oslo, Norway.
authors: Bente Brokstad
authors: BB
authors: Herlofson
authors: Department of Oral Surgery and Oral Medicine, Faculty of Dentistry, University of Oslo, Oslo, Norway.
authors: Karen Marie
authors: KM
authors: Giltvedt
authors: Department of Oral and Maxillofacial Surgery, Aarhus University and University Hospital, Aarhus, Denmark.
authors: Sven Erik
authors: SE
authors: Norholt
authors: Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
authors: Vera
authors: V
authors: Ehrenstein
keywords: ONJ; Scandinavia; antiresorptive; bisphosphonate; cancer; classification; denosumab; epidemiology; jaws; osteonecrosis; osteoporosis
references: Breast Cancer Res Treat. 2010 Jul;122(1):181-8
references: 20361252
references: J Evid Based Dent Pract. 2012 Sep;12(3 Suppl):233-47
references: 23040351
references: Arch Bronconeumol. 2012 Jun;48(6):218-9
references: 22429334
references: J Bone Miner Res. 2007 Oct;22(10):1479-91
references: 17663640
references: Clin Epidemiol. 2013 Aug 01;5:263-7
references: 23946670
references: Clin Epidemiol. 2013;5:1-7
references: 23323023
references: Osteoporos Int. 2013 Dec;24(12):2929-53
references: 24146095
references: Support Care Cancer. 2010 Aug;18(8):1099-106
references: 20411279
references: Ann Oncol. 2012 May;23(5):1341-7
references: 21986094
references: Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Mar;113(3):e1-3
references: 22676833
references: Obstet Gynecol. 2013 Jun;121(6):1291-9
references: 23812464
references: Breast J. 2013 Sep-Oct;19(5):504-11
references: 23800050
references: Cancer Epidemiol. 2012 Aug;36(4):381-3
references: 22534488
references: J Clin Oncol. 2011 Mar 20;29(9):1125-32
references: 21343556
references: Clin Cancer Res. 2008 Apr 15;14 (8):2387-95
references: 18413829
references: Lancet. 2012 Jan 7;379(9810):39-46
references: 22093187
references: J Oral Maxillofac Surg. 2010 Nov;68(11):2837-45
references: 20971371
references: Oral Oncol. 2012 Aug;48(8):753-7
references: 22401869
references: Aust Endod J. 2009 Dec;35(3):119-30
references: 19961450
references: J Craniomaxillofac Surg. 2012 Jun;40(4):303-9
references: 21676622
references: J Oral Maxillofac Surg. 2009 Apr;67(4):850-5
references: 19304045
references: Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 Feb;117(2):204-13
references: 24332520
references: Support Care Cancer. 2013 Dec;21(12):3483-90
references: 23955094
references: Br J Cancer. 2012 Nov 6;107(10 ):1665-71
references: 23132391
references: J Oral Maxillofac Surg. 2012 Mar;70(3):632-5
references: 21757280
references: J Clin Oncol. 2008 Aug 20;26(24):4037-8
references: 18711196
references: Nat Rev Drug Discov. 2012 May;11(5):401-19
references: 22543469
references: Br J Oral Maxillofac Surg. 2015 Jan;53(1):13-7
references: 25282593
references: Am J Med. 2010 Nov;123(11):1060-4
references: 20851366
references: Blood. 2008 Oct 1;112(7):2709-12
references: 18594024
references: Int J Immunopathol Pharmacol. 2009 Oct-Dec;22(4):1121-3
references: 20074477
references: Gynecol Oncol. 2009 Mar;112(3):605-9
references: 19136147
references: J Oral Maxillofac Surg. 2007 Mar;65(3):369-76
references: 17307580
references: Osteoporos Int. 2013 Jan;24(1):237-44
references: 22707065
references: Small GTPases. 2011 May;2(3):117-130
references: 21776413
references: J Oral Maxillofac Surg. 2004 May;62(5):527-34
references: 15122554
references: J Oral Maxillofac Surg. 2010 Feb;68(2):243-53
references: 19772941
references: Int J Oral Maxillofac Surg. 2012 Nov;41(11):1397-403
references: 22840716
references: J Clin Oncol. 2009 Nov 10;27(32):5356-62
references: 19805682
references: Lancet. 2011 Mar 5;377(9768):813-22
references: 21353695
references: Acta Odontol Scand. 2013 Nov;71(6):1386-90
references: 23351164
references: Oral Maxillofac Surg. 2011 Mar;15(1):63-6
references: 20401503
references: J Oral Maxillofac Surg. 2015 Mar;73(3):377
references: 25683041
references: BMJ Case Rep. 2012 Oct 22;2012:null
references: 23093510
references: Bone. 2012 May;50(5):1023-5
references: 22586699
references: J Oral Maxillofac Surg. 2014 Jan;72(1):76-82
references: 23992777
references: Ann Oncol. 2008 Dec;19(12):2091-2
references: 18977851
references: J Oral Maxillofac Surg. 2009 May;67(5 Suppl):61-70
references: 19371816
references: J Oral Maxillofac Surg. 2003 Sep;61(9):1115-7
references: 12966493